Treatment of acute respiratory distress syndrome

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/66 (2006.01) A61K 38/17 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2637644

Patients suffering from acute respiratory distress syndrome or acute lung injury are treated by administering to the patients a therapeutically effective dosage of a surfactant that includes SP-B and phospholipid at a concentration of SP-B relative to concentration of phospholipid that is sufficient to produce detectable SP-B dependent activity.

La présente invention concerne des patients souffrant d~un syndrome de détresse respiratoire aigu ou d~une lésion pulmonaire aiguë qui sont traités par l'administration d~une dose thérapeutiquement efficace d'un tensioactif comprenant un SP-B et un phospholipide selon un rapport de concentration de SP-B sur le phospholipide suffisant pour produire une activité dépendant de SP-B détectable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of acute respiratory distress syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of acute respiratory distress syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of acute respiratory distress syndrome will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1692543

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.